PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10694199-2 2000 We previously found evidence for a functional interaction between the mesolimbic dopamine system and circulating vasopressin and the present study was performed to test the hypothesis that mesolimbic dopamine stimulation modulates the cardiovascular effects of vasopressin. Dopamine 200-208 arginine vasopressin Rattus norvegicus 261-272 10694199-9 2000 In conclusion, these results suggest that the mesolimbic dopamine system, in addition to its well-known role in the regulation of behaviour, modulates cardiovascular control by potentiating the effects of vasopressin on mean arterial pressure. Dopamine 57-65 arginine vasopressin Rattus norvegicus 205-216 10386248-7 1999 Outside the CNS, dopamine may regulate blood pressure via pressure controls that act with intermediate rapidity (e.g. stress relaxation, arginine vasopressin and renin-angiotensin vasoconstriction), as well as those systems related to the long-term control of body fluid volume. Dopamine 17-25 arginine vasopressin Rattus norvegicus 146-157 10638427-6 1999 The increase in plasma AVP by dopamine was not blocked by the preinfusion of the D2-antagonist sulpiride (13 nmol) into the AV3V 10 min before, but was abolished by that of the D1-antagonist SCH-23390 (8 nmol). Dopamine 30-38 arginine vasopressin Rattus norvegicus 23-26 9873154-0 1998 Vasopressin induces dopamine release and cyclic AMP efflux from the brain of water-deprived rats: inhibitory effect of vasopressin V2 receptor-mediated phosphorylation. Dopamine 20-28 arginine vasopressin Rattus norvegicus 0-11 9673440-2 1998 Stimulation of the mesolimbic dopamine system, by micro-injection of the substance P analogue [pGlu5,MePhe8,Sar9] substance P (DiMe-C7) into the ventral tegmental area induced a prolonged increase in blood pressure and circulating levels of vasopressin. Dopamine 30-38 arginine vasopressin Rattus norvegicus 241-252 9689005-0 1998 Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. Dopamine 0-8 arginine vasopressin Rattus norvegicus 18-29 9689005-1 1998 Dopamine inhibits Na+ and water reabsorption in the rat cortical collecting duct (CCD) in the presence of arginine vasopressin (AVP). Dopamine 0-8 arginine vasopressin Rattus norvegicus 115-126 9673440-7 1998 The central dopamine-mediated decrease in baroreflex sensitivity may be involved in functionally potentiating the circulatory actions of vasopressin. Dopamine 12-20 arginine vasopressin Rattus norvegicus 137-148 8770171-3 1996 At doses > or = 1 microM, dopamine inhibited arginine vasopressin (AVP)-dependent Na+ and water transport (measured by the unidirectional lumen-to-bath 22Na+ flux and the transepithelial voltage) and osmotic water permeability (Pf). Dopamine 29-37 arginine vasopressin Rattus norvegicus 57-68 3993453-8 1985 It is postulated that in case vasopressin affects retrieval processes the site of action is located in the amygdala and the dentate gyrus of the hippocampal complex with dopamine and serotonin as the respective neurotransmitter systems involved. Dopamine 170-178 arginine vasopressin Rattus norvegicus 30-41 8458064-7 1993 Treatment with the dopamine agonist bromocriptine to reduce prolactin secretion raised levels of VP mRNA in the NIL only. Dopamine 19-27 arginine vasopressin Rattus norvegicus 97-99 1471453-0 1992 Effect of dopamine injection into the anteroventral third ventricular region and the paraventricular nucleus on vasopressin secretion in conscious rats. Dopamine 10-18 arginine vasopressin Rattus norvegicus 112-123 1471453-2 1992 The injections of 156 nmol (30 micrograms) dopamine into the cerebral ventricle produced transient rises in plasma AVP 5 min later. Dopamine 43-51 arginine vasopressin Rattus norvegicus 115-118 1471453-3 1992 When the dose of dopamine was reduced to 26 nmol (5 micrograms), the increase in plasma AVP was not provoked any more. Dopamine 17-25 arginine vasopressin Rattus norvegicus 88-91 1471453-4 1992 However, injections of 26 nmol dopamine into the paraventricular nucleus greatly augmented plasma AVP 5 and 15 min later. Dopamine 31-39 arginine vasopressin Rattus norvegicus 98-101 1604042-0 1992 Effects of dopamine on renal receptors for arginine vasopressin. Dopamine 11-19 arginine vasopressin Rattus norvegicus 52-63 8630527-10 1996 Dopamine injection into the anteroventral third ventricular region increased plasma vasopressin 5 min later, without affecting plasma osmolality, electrolytes or arterial pressure. Dopamine 0-8 arginine vasopressin Rattus norvegicus 84-95 8137176-0 1994 A facilitatory role of vasopressin in hypoxia/hypoglycemia-induced impairment of dopamine release from rat striatal slices. Dopamine 81-89 arginine vasopressin Rattus norvegicus 23-34 8137176-3 1994 In this study, we investigated the effect of arginine vasopressin (AVP) on hypoxia/hypoglycemia-induced impairment of dopamine release from striatal slices. Dopamine 118-126 arginine vasopressin Rattus norvegicus 54-65 1775194-0 1991 Carrier-mediated outward transport of dopamine from adrenergic varicosities of the vas deferens of reserpine-pretreated rats. Dopamine 38-46 arginine vasopressin Rattus norvegicus 83-86 2720392-0 1989 Facilitatory role of central dopamine in the osmotic release of vasopressin. Dopamine 29-37 arginine vasopressin Rattus norvegicus 64-75 2720392-2 1989 injection of the dopamine antagonist haloperidol (0.15 mumol) blocked increases in plasma vasopressin (AVP) and arterial pressure caused by i.c.v. Dopamine 17-25 arginine vasopressin Rattus norvegicus 90-101 3774591-5 1986 The suppression of PRL release by AVP appears to be mediated by dopamine since 5 micrograms AVP failed to inhibit PRL release in animals pretreated with the dopamine antagonist domperidone. Dopamine 64-72 arginine vasopressin Rattus norvegicus 34-37 6395937-6 1984 It is concluded that the present results may explain the effect of centrally injected dopamine on vasopressin and oxytocin release. Dopamine 86-94 arginine vasopressin Rattus norvegicus 98-109 6694785-0 1984 Opioid and dopamine involvement in prolactin release induced by arginine vasotocin and vasopressin in the male rat. Dopamine 11-19 arginine vasopressin Rattus norvegicus 87-98 6699783-0 1984 Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat. Dopamine 19-27 arginine vasopressin Rattus norvegicus 31-42 6699783-2 1984 micro-injections of dopamine on vasopressin (AVP) release was investigated in normally hydrated and hydrated rats anaesthetized with urethane, hormone concentrations being determined by radioimmunoassay. Dopamine 20-28 arginine vasopressin Rattus norvegicus 32-43 6699783-2 1984 micro-injections of dopamine on vasopressin (AVP) release was investigated in normally hydrated and hydrated rats anaesthetized with urethane, hormone concentrations being determined by radioimmunoassay. Dopamine 20-28 arginine vasopressin Rattus norvegicus 45-48 6699783-6 1984 Pimozide (400 micrograms/kg) blocked the fall in AVP concentrations following dopamine. Dopamine 78-86 arginine vasopressin Rattus norvegicus 49-52 6699783-11 1984 An injection of 25 micrograms dopamine in these animals produced an increase in AVP concentrations to 1.8 +/- 0.51 microunits/ml and a fall in urine flow which could be approximately matched by an infusion of vasopressin of 15 microunits/min. Dopamine 30-38 arginine vasopressin Rattus norvegicus 80-83 6699783-11 1984 An injection of 25 micrograms dopamine in these animals produced an increase in AVP concentrations to 1.8 +/- 0.51 microunits/ml and a fall in urine flow which could be approximately matched by an infusion of vasopressin of 15 microunits/min. Dopamine 30-38 arginine vasopressin Rattus norvegicus 209-220 6694785-1 1984 The potential involvement of the endogenous opioid and dopamine (DA) systems in the mechanism(s) mediating arginine vasotocin (AVT)- and arginine vasopressin (AVP)-induced prolactin (PRL) release was investigated in vivo. Dopamine 55-63 arginine vasopressin Rattus norvegicus 146-157 6694785-1 1984 The potential involvement of the endogenous opioid and dopamine (DA) systems in the mechanism(s) mediating arginine vasotocin (AVT)- and arginine vasopressin (AVP)-induced prolactin (PRL) release was investigated in vivo. Dopamine 65-67 arginine vasopressin Rattus norvegicus 146-157 6861716-5 1983 A similar abolition of the morphine-elicited rise in plasma vasopressin could also be achieved by the iv infusion of small doses of dopamine in normal rats. Dopamine 132-140 arginine vasopressin Rattus norvegicus 60-71 6135776-4 1983 This selective antagonism of dopamine by desipramine was also observed for the separated epididymal and prostatic ends of the rat vas deferens. Dopamine 29-37 arginine vasopressin Rattus norvegicus 130-133 6132323-4 1983 Vasopressin in low concentrations significantly enhanced the activation of caudate adenylate cyclase activity by dopamine. Dopamine 113-121 arginine vasopressin Rattus norvegicus 0-11 6132323-7 1983 These results indicate that vasopressin may not have a direct effect on brain adenylate cyclase activity but appears to modulate the action of dopamine on brain adenylate cyclase. Dopamine 143-151 arginine vasopressin Rattus norvegicus 28-39 6268006-0 1981 The influence of dopamine and dopaminergic agonists on the contractions of field stimulated rat vas deferens. Dopamine 17-25 arginine vasopressin Rattus norvegicus 96-99 6837162-0 1983 [Relation between the effects of the memory neuromodulator arginine-vasopressin and the levels of activity of the serotonin-, dopamine- and noradrenergic systems of the brain]. Dopamine 126-134 arginine vasopressin Rattus norvegicus 68-79 6322066-5 1983 It is likely that the effects of vasopressin on other transmitter systems (e.g. dopamine in the amygdala and serotonin in the hippocampus) correspond with the effect of this neuropeptide on retrieval processes. Dopamine 80-88 arginine vasopressin Rattus norvegicus 33-44 6291687-0 1982 Dopamine acts at the same receptors as noradrenaline in the rat isolated vas deferens. Dopamine 0-8 arginine vasopressin Rattus norvegicus 73-76 6291687-1 1982 1 The proposal that dopamine activates a different population of receptors from those activated by noradrenaline and phenylephrine to cause contraction of the rat vas deferens has been investigated using a preparation of the epididymal half of this tissue. Dopamine 20-28 arginine vasopressin Rattus norvegicus 163-166 7104713-0 1982 Excitatory effect of dopamine on oxytocin and vasopressin reflex releases in the rat. Dopamine 21-29 arginine vasopressin Rattus norvegicus 46-57 7104713-1 1982 The involvement of dopamine in the release of oxytocin and vasopressin was investigated in lactating rats during suckling or after changes in plasma osmolality. Dopamine 19-27 arginine vasopressin Rattus norvegicus 59-70 7104713-2 1982 The effects of intraventricular injections of dopamine, agonists and antagonists, were tested on electrical unit activity of oxytocinergic or vasopressinergic cells in the paraventricular nucleus, on intramammary pressure (index of oxytocin release) and diuresis (index of vasopressin release). Dopamine 46-54 arginine vasopressin Rattus norvegicus 142-153 7104713-11 1982 So, we can postulate that dopamine regulates the reflex release of oxytocin and vasopressin in the hypothalamus. Dopamine 26-34 arginine vasopressin Rattus norvegicus 80-91 6268006-1 1981 In isolated field stimulated rat vas deferens frequency-response curves were shifted to the right by noradrenaline, dopamine, apomorphine, bromocriptine and nomifensine. Dopamine 116-124 arginine vasopressin Rattus norvegicus 33-36 7469495-0 1980 [Supersensitivity of isolated rat vas deferens to dopamine in animals pretreated wit reserpine and haloperidol (author"s transl)]. Dopamine 50-58 arginine vasopressin Rattus norvegicus 34-37 6973462-0 1981 Intraventricular administration of vasopressin and oxytocin effects the steady-state levels of serotonin, dopamine and norepinephrine in rat brain. Dopamine 106-114 arginine vasopressin Rattus norvegicus 35-46 7004741-9 1980 The results suggest that dopamine and angiotensin have opposite effects on the neurosecretion of vasopressin. Dopamine 25-33 arginine vasopressin Rattus norvegicus 97-108 466869-4 1979 Dopamine was three to five times as potent as noradrenaline on the rat vas deferens, but was considerably less potent than noradrenaline on the guinea-pig vas deferens. Dopamine 0-8 arginine vasopressin Rattus norvegicus 71-74 526075-0 1979 Potentiation of dopamine-induced contractions of the rat vas deferens by low concentrations of its antagonists. Dopamine 16-24 arginine vasopressin Rattus norvegicus 57-60 526075-1 1979 Pimozide (5--10 ng/ml), haloperidol (0.5--5 ng/ml) and yohimbine (2--5 ng/ml) selectively potentiated dopamine-induced and methoxamine-induced contractions of the rat vas deferens. Dopamine 102-110 arginine vasopressin Rattus norvegicus 167-170 466869-4 1979 Dopamine was three to five times as potent as noradrenaline on the rat vas deferens, but was considerably less potent than noradrenaline on the guinea-pig vas deferens. Dopamine 0-8 arginine vasopressin Rattus norvegicus 155-158 466869-7 1979 On the rat vas deferens the pA2 values against noradrenaline and dopamine were 7.6 and 7.4, respectively. Dopamine 65-73 arginine vasopressin Rattus norvegicus 11-14 466869-10 1979 On the rat vas deferens, the pA2 value against dopamine was 7.9. t. The beta-adrenoceptor blocking agents, propranolol and oxprenolol slightly enhanced dopamine-induced contractions on vasa deferentia of both species. Dopamine 47-55 arginine vasopressin Rattus norvegicus 11-14 466869-10 1979 On the rat vas deferens, the pA2 value against dopamine was 7.9. t. The beta-adrenoceptor blocking agents, propranolol and oxprenolol slightly enhanced dopamine-induced contractions on vasa deferentia of both species. Dopamine 152-160 arginine vasopressin Rattus norvegicus 11-14 466869-12 1979 It is suggested that dopamine might act on both a-adrenoceptors and dopaminoceptors in the vas deferens, and that the component due to activation of dopaminoceptors is greater in the rat than the guinea-pig. Dopamine 21-29 arginine vasopressin Rattus norvegicus 91-94 105820-1 1978 On isolated Rat vas deferens the contracting responses of noradrenaline and dopamine are increased by mescaline (23 micromoles) and decreased by lysergide (15 micromoles). Dopamine 76-84 arginine vasopressin Rattus norvegicus 16-19 555128-1 1979 Dopamine, noradrenaline, tyramine, amantadine and apomorphine produced concentration-related contractions of the rat vas deferens "in vitro". Dopamine 0-8 arginine vasopressin Rattus norvegicus 117-120 475507-4 1979 Vas deferentia from reserpinized animals showed reduced contractions upon electrical stimulation but became supersensitive to dopamine and noradrenaline. Dopamine 126-134 arginine vasopressin Rattus norvegicus 0-3 19605017-4 1977 Vasopressin treatment decreased the hypothalamic, septal and striatal dopamine (DA) levels. Dopamine 70-78 arginine vasopressin Rattus norvegicus 0-11 41869-3 1978 Acetylcholine and histamine stimulated the release of AVP at the hypothalamic and pituitary levels; dopamine and norepinephrine released AVP in a dose related manner only from the hypothalamus; angiotensin II released AVP in the same fashion only from the pituitary gland. Dopamine 100-108 arginine vasopressin Rattus norvegicus 137-140 41869-3 1978 Acetylcholine and histamine stimulated the release of AVP at the hypothalamic and pituitary levels; dopamine and norepinephrine released AVP in a dose related manner only from the hypothalamus; angiotensin II released AVP in the same fashion only from the pituitary gland. Dopamine 100-108 arginine vasopressin Rattus norvegicus 137-140 41869-4 1978 AVP secretion stimulated by dopamine and norepinephrine may represent synaptic inputs which are localized at the hypothalamus and must be distinguished from the site of action at the pituitary gland of angiotensin II. Dopamine 28-36 arginine vasopressin Rattus norvegicus 0-3 19605017-4 1977 Vasopressin treatment decreased the hypothalamic, septal and striatal dopamine (DA) levels. Dopamine 80-82 arginine vasopressin Rattus norvegicus 0-11 1252961-1 1976 The direct application of crystalline dopamine, D-amphetamine or scopolamine in microgram quantities to the ventral anterior region of the corpus striatum (VAS) of rats increased their responding for food on a modified DRL-30 sec schedule of reinforcement. Dopamine 38-46 arginine vasopressin Rattus norvegicus 156-159 602198-0 1977 A comparison of the effect of cocaine desipramine on the contractions of the isolated vas deferens of the rat induced by dopamine and noradrenaline [proceedings]. Dopamine 121-129 arginine vasopressin Rattus norvegicus 86-89 988183-10 1976 The fact that the isolated hypothalamus can be stimulated by dopamine and acetylcholine to release increased amount of oxytocin and arginine vasopressin raises the question of the origin and fate of the hormones released in this way. Dopamine 61-69 arginine vasopressin Rattus norvegicus 141-152 988183-13 1976 In similar doses, both dopamine and noradrenaline injected into the lateral cerebral ventricles of the brain of the anaesthetized, hydrated, lactating rat caused the release of arginine vasopressin and oxytocin. Dopamine 23-31 arginine vasopressin Rattus norvegicus 186-197 1252961-4 1976 These results were interpreted as being consistent with the idea of a dopamine-acetylcholine antagonism in the VAS whose net output modulate behavioral inhibition. Dopamine 70-78 arginine vasopressin Rattus norvegicus 111-114 12468105-0 2002 Inhibitory effect of galanin on dopamine-induced enhanced vasopressin secretion in rat neurohypophyseal tissue cultures. Dopamine 32-40 arginine vasopressin Rattus norvegicus 58-69 31691406-0 2021 Vasopressin in the lateral septum decreases conditioned place preference to amphetamine and nucleus accumbens dopamine release. Dopamine 110-118 arginine vasopressin Rattus norvegicus 0-11 29875448-0 2018 Involvement of dopamine, but not norepinephrine, in the sex-specific regulation of juvenile socially rewarding behavior by vasopressin. Dopamine 15-23 arginine vasopressin Rattus norvegicus 123-134 21907406-4 2011 The vasopressin level substantially increased after epinephrine, norepinephrine, serotonin, histamine, dopamine or K(+) treatment. Dopamine 103-111 arginine vasopressin Rattus norvegicus 4-15 20040961-12 2008 The extract inhibited contractions produced by dopamine on isolated rat vas deferens. Dopamine 47-55 arginine vasopressin Rattus norvegicus 72-75 12468105-4 2002 Dopamine (DA) and the DA-active drugs apomorphine (APM) and Pro-Lys-Gly (PLG) (10(-6) M in each medium) increased the VP level of NH tissue cultures. Dopamine 0-8 arginine vasopressin Rattus norvegicus 118-120 12468105-4 2002 Dopamine (DA) and the DA-active drugs apomorphine (APM) and Pro-Lys-Gly (PLG) (10(-6) M in each medium) increased the VP level of NH tissue cultures. Dopamine 10-12 arginine vasopressin Rattus norvegicus 118-120 11504796-1 2001 We compared the effects of dopamine and norepinephrine on vasopressin (AVP)-stimulated increases in osmotic water permeability (Pf) and cAMP accumulation in the rat inner medullary collecting duct (IMCD). Dopamine 27-35 arginine vasopressin Rattus norvegicus 58-69 11179778-0 2001 Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures. Dopamine 11-19 arginine vasopressin Rattus norvegicus 66-77 11179778-0 2001 Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures. Dopamine 24-32 arginine vasopressin Rattus norvegicus 66-77